Hong Kong
· Delayed Price · Currency is HKD Zhaoke Ophthalmology Statistics
Total Valuation
HKG:6622 has a market cap or net worth of HKD 950.28 million. The enterprise value is -63.42 million.
| Market Cap | 950.28M |
| Enterprise Value | -63.42M |
Important Dates
The last earnings date was Friday, March 21, 2025.
| Earnings Date | Mar 21, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:6622 has 546.14 million shares outstanding. The number of shares has increased by 0.41% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 546.14M |
| Shares Change (YoY) | +0.41% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.03% |
| Owned by Institutions (%) | 18.13% |
| Float | 348.38M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 12.88 |
| PB Ratio | 0.47 |
| P/TBV Ratio | 0.60 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 0.25 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.16, with a Debt / Equity ratio of 0.13.
| Current Ratio | 5.16 |
| Quick Ratio | 3.88 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -29.98 |
Financial Efficiency
Return on equity (ROE) is -12.03% and return on invested capital (ROIC) is -8.05%.
| Return on Equity (ROE) | -12.03% |
| Return on Assets (ROA) | -7.64% |
| Return on Invested Capital (ROIC) | -8.05% |
| Return on Capital Employed (ROCE) | -14.76% |
| Revenue Per Employee | 250,927 |
| Profits Per Employee | -859,638 |
| Employee Count | 294 |
| Asset Turnover | 0.03 |
| Inventory Turnover | 1.67 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +3.15% in the last 52 weeks. The beta is 1.06, so HKG:6622's price volatility has been similar to the market average.
| Beta (5Y) | 1.06 |
| 52-Week Price Change | +3.15% |
| 50-Day Moving Average | 1.79 |
| 200-Day Moving Average | 1.48 |
| Relative Strength Index (RSI) | 48.27 |
| Average Volume (20 Days) | 2,236,750 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:6622 had revenue of HKD 73.77 million and -252.73 million in losses. Loss per share was -0.46.
| Revenue | 73.77M |
| Gross Profit | 55.12M |
| Operating Income | -303.19M |
| Pretax Income | -252.73M |
| Net Income | -252.73M |
| EBITDA | -267.35M |
| EBIT | -303.19M |
| Loss Per Share | -0.46 |
Balance Sheet
The company has 1.27 billion in cash and 253.90 million in debt, giving a net cash position of 1.01 billion or 1.86 per share.
| Cash & Cash Equivalents | 1.27B |
| Total Debt | 253.90M |
| Net Cash | 1.01B |
| Net Cash Per Share | 1.86 |
| Equity (Book Value) | 2.02B |
| Book Value Per Share | 3.70 |
| Working Capital | 1.39B |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 74.72% |
| Operating Margin | -410.98% |
| Pretax Margin | -342.58% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
HKG:6622 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.41% |
| Shareholder Yield | -0.41% |
| Earnings Yield | -26.60% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |